|

TUB-030 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tubulis GmbH1

Indications

  • SCLC1
  • TNBC - Triple-Negative Breast Cancer1
  • CRC1
  • HNSCC1
  • Advanced Solid Tumors1

New Haven, Connecticut1 trial

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Yale Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.